主管:国家卫生健康委员会
主办:国家卫生健康委医院管理研究所
中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)核心库期刊
《中文核心期刊要目总览》核心期刊

中国护理管理 ›› 2019, Vol. 19 ›› Issue (10): 1482-1486.doi: 10.3969/j.issn.1672-1756.2019.10.011

• 论 著 • 上一篇    下一篇

肾移植患者免疫抑制剂服药障碍及其影响因素研究

周鸣鸣 王春燕 刘欣仪 黄俊 姚宏雯 周玲   

  1. 无锡太湖学院护理学院,214064 江苏省(周鸣鸣,王春燕,刘欣仪,黄俊,姚宏雯);中南大学湘雅三医院器官移植科(周玲)
  • 出版日期:2019-10-15 发布日期:2019-10-15
  • 通讯作者: 王春燕,硕士,助教,E-mail:767323161@qq.com
  • 作者简介:周鸣鸣,博士,副教授,副院长
  • 基金资助:
    无锡市科研课题(CSZON1737);无锡太湖学院横向课题(17WURD009)

Study on immunosuppressant therapy barrier of renal transplant patients and its influencing factors

ZHOU Mingming, WANG Chunyan, LIU Xinyi, HUANG Jun, YAO Hongwen, ZHOU Ling   

  1. School of Nursing, Taihu University of Wuxi, Jiangsu province, 214064, China
  • Online:2019-10-15 Published:2019-10-15
  • Contact: E-mail:767323161@qq.com

摘要: 目的:分析肾移植患者服用免疫抑制剂期间的服药障碍水平及其影响因素。方法:选取长沙市某三级甲等医院符合入选标准的181例肾移植术后患者为研究对象,采用汉化版的免疫抑制剂服药障碍量表进行问卷调查。结果:服药障碍总得分(29.03±7.01)分,其中不可控因素维度得分(19.00±4.68)分,可控因素维度得分(10.03±3.21)分。不可控因素维度的均分为2.38分,可控因素维度的均分为2.00分,差异有统计学意义(P<0.05)。移植术后时间、患者年龄、患者教育程度为肾移植患者免疫抑制剂服药障碍的影响因素。结论:肾移植术后患者均面临一定程度的服药障碍,其中每天服用免疫抑制剂的次数太多和数量太多是患者感受最大的服药障碍;年纪较轻,教育程度低和移植术后时间较久的患者相比其他患者经历更多的服药障碍。

关键词: 肾移植;免疫抑制剂;服药依从性;服药负担

Abstract: Objective: To investigate the immunosuppressant therapy barrier of renal transplant patients and its influencing factors. Methods: A total of 181 patients with renal transplantation who met the inclusion criteria in a tertiary grade A hospital in Changsha were recruited as subjects between June and November of 2017. General information questionnaire and the Chinese version of Immunosuppressant Therapy Barrier Scale (ITBS) were used to collect data. Results: Renal transplant patients showed different degree of immunosuppressant therapy barrier. The total score of immunosuppressant therapy barrier score was (29.03±7.01), among which the uncontrollable factor dimension score was (19.00±4.68), and the controllable factor dimension score was (10.03±3.21). Among the influencing factors of therapy barrier, the time of transplantation, the age and educational level of patients were statistically significant. Conclusion: After renal transplantation, patients are facing a certain degree of immunosuppressant therapy barriers. The most common immunosuppressant therapy barrier is the high frequency and large amount of taking immunosuppressant. Patients who are younger, with lower educational level and have longer post-transplantation experience have more immunosuppressant therapy barriers than others.

Key words: kidney transplantation; immunosuppressant; medication adherence; pill burden

中图分类号: 

  • R47